Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Medical collagen sponges are absorbable biomaterials composed primarily of purified Type I or microfibrillar collagen. They are widely used in surgical and wound care settings to promote hemostasis (control bleeding), support tissue regeneration, and as carriers for local drug delivery such as antibiotics or anti-inflammatory agents. These sponges enhance platelet aggregation and fibrin formation at the site of application, facilitating clot formation and wound healing[3][4][2]. In clinical practice, they are applied topically to wounds or surgical sites and can be loaded with drugs like gentamicin for infection control in chronic osteomyelitis[1]. The porous structure allows for cell attachment, proliferation, nutrient flow, and controlled release of incorporated medications[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on medical collagen sponge.